We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

NIH Announces 15 Clinical and Translational Science Awards


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NIH Announces 15 Clinical and Translational Science Awards "

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

Translating basic discoveries into new treatments that tangibly improve human health requires innovative collaborations and resources, as well as a diverse, highly trained workforce. To help meet these needs, the National Institutes of Health today announced more than $79 million in fiscal year 2013 funding to support 15 Institutional Clinical and Translational Science Awards (CTSA).

Led by the National Center for Advancing Translational Sciences (NCATS), the CTSA program catalyzes improvements across the entire spectrum of translational research through efforts to broadly develop, demonstrate and disseminate health interventions. It serves as a connector to engage key partners including other NIH institutes and centers, patient groups, communities, health care providers, industry, and regulatory organizations.

“Science and technology are progressing at an unprecedented pace, and the CTSA program — which represents NIH’s largest single investment in clinical research — is helping researchers harness these innovations and deliver improved diagnostics, treatments and cures for disease,” said NIH Director Francis S. Collins, M.D., Ph.D.

These latest awards represent NIH’s commitment to the CTSA program, which supports a consortium of more than 60 research institutions across the country that is focused on strengthening translational research. Under NCATS’ leadership, the program is focused on solving roadblocks common to clinical translational efforts for all diseases.

“The CTSA Consortium is leading national efforts to enhance the efficiency, quality, and safety of translational research, no matter the disease or condition,” said NCATS Director Christopher P. Austin, M.D. “This aligns with the NCATS mission to create new technologies and methods that can be applied widely to streamline development and implementation of interventions that improve human health.”

The 2013 awards expand consortium representation to New Hampshire with an award to Dartmouth, extending the network to 31 states and the District of Columbia. The institutions receiving five-year awards are:

Albert Einstein College of Medicine, New York City
Dartmouth College, Hanover, N.H.
Duke University, Durham, N.C.
Harvard Medical School, Boston
Indiana University, Indianapolis
Johns Hopkins University, Baltimore
Ohio State University, Columbus
Scripps Research Institute, La Jolla, Calif.
Stanford University, Stanford, Calif.
Tufts University, Boston
University of Colorado, Denver
University of North Carolina at Chapel Hill
University of Texas Health Science Center, San Antonio
University of Texas Southwestern Medical Center, Dallas
University of Utah, Salt Lake City

View descriptions of these awardees and other CTSA institutions here.

Advertisement